Cristina Montón

OS-010 Management of patients with primary biliary cholangitis in the post-obeticholic era: real-world effectiveness data on elafibranor and seladelpar from the ColHai registry

Alvaro Diaz-Gonzalez, Cristina Montón, Marina Brosell, Agustin Castiella et autres

SAT-538 Quantification of hepatic steatosis: a prospective multicenter head-to-head comparison of histopathology, digital pathology and MRI-PDFF

David Marti-Aguado, Clara Alfaro-Cervello, Matías Fernández-Patón, Gustavo Rojas-Echarry et autres

WED-150 Refining the EASL two-step strategy for referral of patients with MASLD: a prospective multicenter primary care study

David Marti-Aguado, Marta Hernández Conde, Rosa Murria, Elba Llop Herrera et autres

SAT-291 Reduced symptom prevalence but significant quality of life impact in patients with primary biliary cholangitis in Spain

Helena Hernández-Évole, Ignasi Olivas, Diogo Simas, Ismael El Hajra Martinez et autres

125 - NUEVO GOLD STANDARD PARA LA EVALUACIÓN DE LA ESTEATOSIS HEPÁTICA

David Marti-Aguado, Clara Alfaro-Cervelló, Matías Fernández-Patón, María José Gastaldo et autres

MANEJO DE LAS PACIENTES CON COLANGITIS BILIAR PRIMARIA (CBP) EN LA ERA POSOBETICÓLICO (OCA): PRIMEROS DATOS DE EFECTIVIDAD EN VIDA REAL DE ELAFIBRANOR (ELA) Y SELADELPAR (SEL) DEL REGISTRO COLHAI

Alvaro Diaz-González, Cristina Montón, Marina Brosell, Agustin Castiella et autres

OPTIMIZACIÓN DEL ALGORITMO EASL DE DERIVACIÓN DESDE ATENCIÓN PRIMARIA EN LA ENFERMEDAD HEPÁTICA METABÓLICA

David Marti-Aguado, Marta Hernández-Conde, Rosa Murria, Elba Llop et autres

132 - SÍNTOMAS Y CALIDAD DE VIDA EN CBP: MÁS ALLÁ DE LA RESPUESTA BIOQUÍMICA

Helena Hernández-évole, Ignasi Olivas, Diogo Simas, Ismael El Hajra et autres

Effects of bariatric surgery on neurological disturbances and quality of life in patients with metabolic dysfunction-associated steatotic liver disease and obesity: a prospective longitudinal study

Concepción Gómez, María Lapeña, Clara Alfaro‐Cervelló, Alessandra Fiorillo et autres

BACKGROUND: Neurological impairment has been recognized in up to 70% of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity, which can lead to poor quality of life (QoL). OBJECTIVES: To evaluate the impact of bariatric surgery on neurological alterations, QoL, …

es (code pays fourni par la source)

Digital pathology and lipid droplet size as a key determinant of discrepancies between histology and MRI gradings in steatotic liver disease

David Martí Aguado, Clara Alfaro‐Cervelló, Matías Fernández-Patón, Amadeo Ten‐Esteve et autres

Abstract Background Hepatic steatosis grades derived from magnetic resonance imaging proton density fat fraction (MRI-PDFF) might disagree with those determined by histology. We investigated whether the size distribution of lipid droplets (LDs) assessed with digital image analysis (DIA) explains the discrepancies between …

es, at, us (code pays fourni par la source)

THU-326 Epidemiological and clinical differences in primary sclerosing cholangitis between men and women in Spain: a multicenter analysis of 697 patients

Sergio Rodríguez‐Tajes, Ana Arencibia Almeida, Elena Gómez Domínguez, Cristina Montón et autres

THU-038 Patients with chronic liver disease present elevated plasma levels of peptidylprolyl isomerase C associated with the degree of fibrosis

Cristina Benavides, Isabel Fuster‐Martínez, Ana M. Benedicto, Fernando Solano et autres